Malaria

Indian Economy glossary

Also called: Plasmodium infection · Topic: Human Capital: Education, Health and Demographic Dividend · NCERT: Beyond NCERT

Meaning

Malaria is a disease caused by Plasmodium parasites. It spreads to people through the bite of an infected female Anopheles mosquito. In India the two main types are P. vivax and P. falciparum. P. vivax can stay dormant (inactive) in the liver and cause a fresh attack weeks or months later; this is called a relapse.

It matters for economics because health is one of the two major sources of human capital (the skills, knowledge and health that make workers productive). Every malaria attack is lost work and lost school. Every case avoided protects the supply of healthy labour.

Explanation

How it spreads and why it keeps coming back

  • The transmission chain
  • An infected mosquito bites a person, and the parasite enters the blood.
  • The person gets fever and becomes a source of infection.
  • Another mosquito bites that person and carries the parasite to the next person.

  • Breaking the chain therefore needs action on two fronts:

  • the parasite: test, treat fully and track every case;
  • the mosquito: integrated vector control and environmental management, such as preventing waterlogging and removing breeding sources. A vector is the carrier of the disease, here the mosquito.

  • Why P. vivax is harder to beat

  • Its dormant liver stage can cause a relapse with no new mosquito bite.
  • So a district can control mosquitoes well and still see cases return.
  • In 2023, just over 48% of estimated malaria cases in WHO's South-East Asia Region were caused by P. vivax.
  • Primaquine is the drug that clears the dormant liver stage. WHO's regional office has called for a more practical way of using it.
  • Patients must finish the full medicine course, because stopping once the fever ends can leave the hidden parasite alive.

Key working terms

  • Indigenous case: malaria caught locally. An imported case is caught somewhere else and brought in.
  • Control means reducing the disease burden. Elimination means stopping local transmission completely, i.e. zero indigenous cases.
  • Reported cases vs estimated cases
  • Reported cases are government counts of people who were tested.
  • WHO's World Malaria Report uses estimates, which include people who were never tested. For example, India had about 6.4 million estimated cases in 2017.
  • A fall in reported cases can mean less disease. It can also mean less testing.

Why malaria is a human capital problem

  • Lost output: a sick worker without medical care has to stay away from work, so output is lost. Health spending directly increases the supply of healthy labour.
  • Lost learning: good health supports cognitive development and regular school attendance. Repeated fever means missed school.
  • External benefit: a person who is treated and protected also protects their neighbours, because the parasite cannot pass through them. Markets price only private benefits, so they do too little to prevent such diseases. This is a classic reason for the state to act.
  • All four forms of health spending apply:
  • preventive (removing breeding sites, bed nets, vaccines);
  • curative (testing and full treatment);
  • social medicine (health literacy, e.g. finishing the medicine course);
  • water and sanitation (no stagnant water).

Simple illustration with numbers

  • India has about 16% of the world's population but only about 0.7% of global malaria cases and about 0.6% of global malaria deaths.
  • 0.7 ÷ 16 ≈ 0.04. So India's share of world malaria cases is less than one-twentieth of its share of world population.
  • But within WHO's South-East Asia Region, India still had half of all estimated cases in 2023. Both facts are true. The baseline you compare against changes the story.

In India

  • Research body: ICMR–National Institute of Malaria Research (ICMR–NIMR), set up in 1977 under ICMR.
  • It studies parasites, vectors, vector control, insecticide resistance and community surveillance.
  • ICMR works under the Department of Health Research (DHR). The DG of ICMR is also Secretary, DHR.

  • Programme arm: the National Centre for Vector Borne Disease Control (NCVBDC) runs malaria control on the ground.

  • Policy framework: the National Framework for Malaria Elimination (NFME) 2016–2030, a plan to eliminate malaria in phases.
  • Targets: zero indigenous cases by 2027 and elimination by 2030.
  • Progress
  • Cases and deaths fell by nearly 80% between 2015 and 2025.
  • High-burden districts fell from 155 to 33.
  • 160 districts reported zero indigenous cases in 2022–2025.
  • Since 2000, India has cut malaria by 17.7 million cases, a 93% drop in case incidence (WHO).
  • India moved out of WHO's High Burden to High Impact (HBHI) group in 2024 (World Malaria Report 2024).

  • Model project: the ICMR–Odisha Government Comprehensive Case Management Project showed that universal testing, complete treatment and strong surveillance can cut transmission, even in remote communities.

  • Cost to households: the release cites out-of-pocket expenditure (money families pay themselves for health care) falling from 63% to 42%.
  • Vaccine: an indigenous malaria vaccine is being developed in Bhubaneswar, with ICMR–NIMR contributing.
  • Where it is hardest: remote, hilly tribal areas of the North-East and Odisha. Forest-based work and sleeping outdoors keep people exposed to mosquitoes. Tribal, migrant and mobile groups are the hardest to reach.

Don't confuse with

  • Control vs elimination: control only reduces cases. Elimination means zero local transmission. The 2027 target counts only indigenous cases, not imported ones.
  • HBHI exit vs malaria-free certification: leaving WHO's high-burden group in 2024 means real progress, not "malaria-free". Sri Lanka had its last indigenous case in 2012 and was certified by WHO only in 2016.
  • 80% fall vs 93% fall: the ~80% fall covers 2015–2025 and comes from government data. The 93% fall in incidence covers the period since 2000 and comes from WHO. Don't swap the baselines.
  • Relapse vs reinfection: a relapse (P. vivax) comes from parasites hidden in the patient's own liver. A reinfection needs a new mosquito bite. Mosquito control stops only the second.

Prelims Hooks

  • Malaria is caused by Plasmodium parasites and spread by female Anopheles mosquitoes. Only P. vivax has the dormant liver stage that causes relapse, and primaquine targets that stage.
  • ICMR–NIMR was set up in 1977. It is an institute of ICMR, which works under the Department of Health Research.
  • Targets: zero indigenous cases by 2027, elimination by 2030, under NFME 2016–2030.
  • India exited WHO's HBHI group in 2024. Trap: "India has been certified malaria-free" is FALSE.
  • India has ~16% of the world's people but ~0.7% of malaria cases and ~0.6% of malaria deaths. High-burden districts fell from 155 to 33.
  • Trap: "Social medicine means free malaria treatment in public hospitals" is FALSE. Social medicine means spreading health literacy, such as teaching patients to finish the full course.

Mains Points

  • The last mile is the hardest. The remaining cases are in forest and tribal areas where the health system is weakest, and among mobile workers. Each case now needs a full investigation to tell indigenous from imported. Fewer cases therefore means more work per case. Scaling the Odisha model to the last 33 districts is the practical answer.
  • Malaria as a human capital and market-failure issue. Prevention has large external benefits that markets do not price. This justifies public spending on prevention, testing and treatment. Lower out-of-pocket costs (63% → 42%) protect poor families from health shocks that push them into poverty and cut lost workdays, which supports the demographic dividend.
  • Gains can reverse. Climate change, unplanned urbanisation and changing mosquito behaviour, along with insecticide and drug resistance (the theme of WHO's World Malaria Report 2025), all threaten progress. Sri Lanka still detects about 40–50 imported cases a year, some from India. India needs a One Health approach and a funded plan for preventing re-introduction after 2030.

Read more